Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Regeneron (NASDAQ: REGN) Delayed: 612.50 +2.56 (0.42%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $613.56    P/E 160.76 
Day Low $594.90    EPS $3.81 
Volume 1,603,868       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 13.71 +0.21 (1.56%)
Previous Close $13.50    52 Week High $5.58 
Open $13.70    52 Week Low $3.60 
Day High $13.75    P/E N/A 
Day Low $13.65    EPS $0.00 
Volume 6,043,348       

SANOFI (NASDAQ: SNY) Delayed: 41.78 -0.6 (1.42%)
Previous Close $42.38    52 Week High $44.76 
Open $40.91    52 Week Low $36.81 
Day High $41.82    P/E N/A 
Day Low $40.89    EPS $0.00 
Volume 5,672,620